Related Experiment Video
Updated: Aug 7, 2026
Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
Published on: May 14, 2012
Interferon inducibility and sensitivity of human teratocarcinoma-derived cell lines
Abstract:
Three cell lines tera I, tera II, and PA1, derived from human teratocarcinomas were tested for their capacity to produce interferon (IFN) and for their sensitivity to both human IFN-alpha and IFN-beta. When treated with Newcastle disease virus or Sendai virus, or a synthetic polyribonucleotide, poly(rI):poly(rC), tera I cells produced no IFN and the 2',5'-oligoadenylate (2-5A) synthetase enzymatic pathway was not activated, although there was an increase in protein kinase. In contrast, tera II and PA1 cells produced IFN and both enzymatic activities were detected. IFN treatment has no effect on the growth of any of the cell lines. Tera I and PA1 cells did not develop resistance to challenge with vesicular stomatitis virus or encephalomyocarditis virus, but the growth of a type-C baboon retrovirus was inhibited. Tera II cells were protected against all three viruses. It appears that human teratocarcinoma cell lines can thus differ greatly in their ability to produce IFN and to respond to it.
Insights
Human teratocarcinoma cell lines show varied responses to interferon (IFN). Some lines produce IFN and resist viral infections, while others do not, highlighting significant differences in their innate immune capabilities.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human teratocarcinoma cell lines offer a model for studying early developmental processes and cellular responses.
- Interferons (IFNs) are crucial cytokines involved in innate immunity against viral infections.
- Understanding cellular responses to IFNs is vital for developing antiviral strategies.
Purpose of the Study:
- To investigate the interferon (IFN) production capacity of human teratocarcinoma cell lines (tera I, tera II, PA1).
- To assess the sensitivity of these cell lines to human IFN-alpha and IFN-beta.
- To evaluate the antiviral defense mechanisms conferred by IFN treatment.
Main Methods:
- Testing three human teratocarcinoma cell lines (tera I, tera II, PA1) for IFN production upon viral or synthetic polynucleotide stimulation.
- Assessing the activation of the 2',5'-oligoadenylate (2-5A) synthetase pathway and protein kinase activity.
- Challenging cell lines with various viruses (vesicular stomatitis virus, encephalomyocarditis virus, baboon retrovirus) after IFN treatment to evaluate resistance.
Main Results:
- Tera I cells failed to produce IFN or activate the 2-5A synthetase pathway, despite increased protein kinase activity.
- Tera II and PA1 cells successfully produced IFN and exhibited activation of both enzymatic pathways.
- IFN treatment did not affect overall cell growth, but tera II cells showed protection against multiple viruses, while tera I and PA1 cells showed partial protection against a retrovirus.
Conclusions:
- Human teratocarcinoma cell lines exhibit significant heterogeneity in their ability to produce and respond to interferons.
- These distinct responses suggest differential innate immune signaling pathways among these cell lines.
- The findings underscore the variability in interferon-mediated antiviral defense in different teratocarcinoma models.
More Related Videos
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
